DK1562604T3 - Prostaglandinforbindelser til behandling af fedme - Google Patents
Prostaglandinforbindelser til behandling af fedmeInfo
- Publication number
- DK1562604T3 DK1562604T3 DK03758747.4T DK03758747T DK1562604T3 DK 1562604 T3 DK1562604 T3 DK 1562604T3 DK 03758747 T DK03758747 T DK 03758747T DK 1562604 T3 DK1562604 T3 DK 1562604T3
- Authority
- DK
- Denmark
- Prior art keywords
- obesity
- treatment
- prostaglandin compounds
- prostaglandin
- compounds
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 2
- -1 Prostaglandin compounds Chemical class 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42033602P | 2002-10-23 | 2002-10-23 | |
| PCT/JP2003/013453 WO2004037268A1 (en) | 2002-10-23 | 2003-10-22 | Prostaglandin compounds for the treatment of obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1562604T3 true DK1562604T3 (da) | 2012-04-02 |
Family
ID=32176556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03758747.4T DK1562604T3 (da) | 2002-10-23 | 2003-10-22 | Prostaglandinforbindelser til behandling af fedme |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8114911B2 (enExample) |
| EP (1) | EP1562604B1 (enExample) |
| JP (1) | JP4705782B2 (enExample) |
| AT (1) | ATE539756T1 (enExample) |
| AU (1) | AU2003274735B2 (enExample) |
| CA (1) | CA2502439C (enExample) |
| DK (1) | DK1562604T3 (enExample) |
| ES (1) | ES2379652T3 (enExample) |
| NZ (1) | NZ539582A (enExample) |
| PT (1) | PT1562604E (enExample) |
| WO (1) | WO2004037268A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5294559B2 (ja) * | 2003-07-03 | 2013-09-18 | スキャンポ・アーゲー | クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物 |
| US7666912B2 (en) * | 2006-03-23 | 2010-02-23 | Massachusetts Eye And Ear Infirmary | Compositions and methods for reducing body fat |
| CA2866067C (en) * | 2011-01-19 | 2015-04-21 | Topokine Therapeutics, Inc. | Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia |
| US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
| WO2014081941A1 (en) | 2012-11-21 | 2014-05-30 | Topokine Therapeutics, Inc. | Methods and compositions for locally increasing body fat |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
| EP2983663B1 (en) | 2013-04-12 | 2020-01-22 | Allergan, Inc. | Sustained release of bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction |
| NO2753788T3 (enExample) | 2013-05-10 | 2018-06-16 | ||
| US9820993B2 (en) | 2013-05-15 | 2017-11-21 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
| US10188661B2 (en) | 2014-06-27 | 2019-01-29 | Topokine Therapeutics, Inc. | Topical dosage regimen |
| US11452703B2 (en) | 2020-05-21 | 2022-09-27 | Peregrine Ophthalmic PTE LTD. | Methods and compositions for reducing adipocyte numbers |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US388919A (en) * | 1888-09-04 | Benjamin scables | ||
| US3888919A (en) * | 1971-03-11 | 1975-06-10 | Upjohn Co | 11,15 dimethyl pge' 1 'and pgf' 1' |
| CA1322749C (en) | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
| US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| US5317032A (en) | 1987-10-02 | 1994-05-31 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Prostaglandin cathartic |
| JP2597629B2 (ja) | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化 |
| NZ226199A (en) | 1988-09-15 | 1991-05-28 | Ueno Seiyaku Oyo Kenkyujo Kk | 13,14-dihydro-15-keto-pgf derivatives and pharmaceutical compositions |
| NZ226198A (en) | 1988-09-15 | 1991-05-28 | Ueno Seiyaku Oyo Kenkyujo Kk | Fervescence (temperature raising) composition comprising 15-keto-pge |
| EP0410646B1 (en) | 1989-07-27 | 1994-03-02 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Treatment of hyperlipidemia with 15-keto-prostaglandin compounds |
| US5234954A (en) * | 1989-07-27 | 1993-08-10 | K.K. Ueno Seiyaku Oyo Kenkyujo | Treatment of hyperlipidemia with 15-keto-prostaglandin compounds |
| JPH085794B2 (ja) * | 1989-07-27 | 1996-01-24 | 株式会社上野製薬応用研究所 | 高脂質血症処置・血中脂質成分低下剤 |
| TW249226B (enExample) | 1990-04-04 | 1995-06-11 | Aderk Ueno Kk | |
| CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| US6022897A (en) | 1995-04-25 | 2000-02-08 | The Salk Institute For Biological Studies | Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| WO1997047595A1 (en) | 1996-06-10 | 1997-12-18 | R-Tech Ueno, Ltd. | Endothelin antagonist |
| WO1999053927A1 (en) | 1998-04-17 | 1999-10-28 | Trustees Of Tufts College | Methods for treating and preventing insulin resistance and related disorders |
| JP2000157260A (ja) | 1998-11-26 | 2000-06-13 | Toyobo Co Ltd | 初代前駆脂肪細胞の分化誘導方法及びその分化用培地 |
| ATE402925T2 (de) | 1999-10-15 | 2008-08-15 | Sucampo Ag | Neue zusammensetzung enthaltend eine bicyclische verbindung und ein glycerid |
| US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
| TWI302100B (en) | 2001-05-02 | 2008-10-21 | Sucampo Ag | Composition for treating drug-induced constipation |
| ATE387204T1 (de) | 2001-05-18 | 2008-03-15 | Sucampo Ag | Zusammensetzung mit induzierendem kathartischen effekt |
| CA2458471C (en) | 2001-08-31 | 2012-07-31 | Sucampo Ag | Prostaglandin analogs as chloride channel opener |
| TWI331920B (en) | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
| TWI263505B (en) | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
| ES2591252T3 (es) | 2002-12-27 | 2016-11-25 | Sucampo Ag | Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional |
| JP5294559B2 (ja) | 2003-07-03 | 2013-09-18 | スキャンポ・アーゲー | クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物 |
| TWI387454B (zh) | 2004-09-02 | 2013-03-01 | 蘇坎波公司 | 治療胃腸道疾病之方法及組成物 |
| US20060281818A1 (en) | 2005-03-21 | 2006-12-14 | Sucampo Ag, North Carolina State University | Method for treating mucosal disorders |
| KR20140069182A (ko) | 2005-04-12 | 2014-06-09 | 수캄포 아게 | 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용 |
-
2003
- 2003-10-22 US US10/531,874 patent/US8114911B2/en not_active Expired - Fee Related
- 2003-10-22 NZ NZ539582A patent/NZ539582A/en not_active IP Right Cessation
- 2003-10-22 ES ES03758747T patent/ES2379652T3/es not_active Expired - Lifetime
- 2003-10-22 CA CA2502439A patent/CA2502439C/en not_active Expired - Fee Related
- 2003-10-22 DK DK03758747.4T patent/DK1562604T3/da active
- 2003-10-22 PT PT03758747T patent/PT1562604E/pt unknown
- 2003-10-22 AT AT03758747T patent/ATE539756T1/de active
- 2003-10-22 JP JP2004546433A patent/JP4705782B2/ja not_active Expired - Fee Related
- 2003-10-22 AU AU2003274735A patent/AU2003274735B2/en not_active Ceased
- 2003-10-22 EP EP03758747A patent/EP1562604B1/en not_active Expired - Lifetime
- 2003-10-22 WO PCT/JP2003/013453 patent/WO2004037268A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2502439A1 (en) | 2004-05-06 |
| CA2502439C (en) | 2011-11-22 |
| EP1562604B1 (en) | 2012-01-04 |
| ES2379652T3 (es) | 2012-04-30 |
| AU2003274735A1 (en) | 2004-05-13 |
| NZ539582A (en) | 2007-07-27 |
| EP1562604A1 (en) | 2005-08-17 |
| JP2006506381A (ja) | 2006-02-23 |
| WO2004037268A1 (en) | 2004-05-06 |
| PT1562604E (pt) | 2012-04-09 |
| US20050261373A1 (en) | 2005-11-24 |
| ATE539756T1 (de) | 2012-01-15 |
| AU2003274735B2 (en) | 2008-12-04 |
| US8114911B2 (en) | 2012-02-14 |
| JP4705782B2 (ja) | 2011-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1767535T3 (da) | Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse | |
| CY1113362T1 (el) | Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως | |
| UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
| UY28014A1 (es) | Compuestos quimicos | |
| ECSP055913A (es) | Inhibidores de las polimerasas víricas | |
| DE60317884T8 (de) | Natriumkanalblocker | |
| SE0100903D0 (sv) | Compounds | |
| DK1385515T3 (da) | Spiropyrazole forbindelser | |
| ECSP056220A (es) | Nuevos compuestos 2-piridiniletilbenzamida | |
| DK1562604T3 (da) | Prostaglandinforbindelser til behandling af fedme | |
| ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
| EA200601295A1 (ru) | Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета | |
| EA200600330A1 (ru) | Замещённые имидазопиримидины для предупреждения и лечения рака | |
| DK1373220T3 (da) | Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DK1511472T3 (da) | Anvendelige forbindelser til behandling af Anthrax og hæmning af letalfaktor | |
| ATE443044T1 (de) | Tace inhibitoren | |
| WO2004030664A3 (en) | New compounds for the inhibition of undesired cell proliferation and use thereof | |
| NO20064344L (no) | Caspaseinhibitorer og anvendelser derav | |
| MA27549A1 (fr) | N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
| NO20050871L (no) | 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer | |
| DK1301475T3 (da) | Arylsulfonamider, som serotoninantagonist til behandling af obesitet | |
| BR0214445B1 (pt) | processos para a produção de compostos. | |
| ATE372982T1 (de) | 2-(3-sulfonylamino-2-oxopyrrolidin-1- yl)propanamide als factor xa inhibitoren |